CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis

CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis

Библиографические подробности
Главные авторы:	Lutgens, E, Mulder, WJM, Monaco, C
Другие авторы:	CHECKPOINT ATHERO consortium
Формат:	Journal article
Язык:	English
Опубликовано:	Oxford University Press 2023

Схожие документы

Risk factors in coronary atherosclerosis athero-inflammation: the meeting point
по: Altman Raul
Опубликовано: (2003-07-01)

Immune checkpoints as therapeutic targets in autoimmunity
по: Paluch, C, и др.
Опубликовано: (2018)

Acute coronary disease Athero-Inflammation: Therapeutic approach
по: Altman Raul
Опубликовано: (2003-06-01)

The ATHERO-AF Study
по: Michael D. Ezekowitz, MBChB, DPhil, и др.
Опубликовано: (2024-08-01)

Immune Checkpoints as Therapeutic Targets in Autoimmunity
по: Christopher Paluch, и др.
Опубликовано: (2018-10-01)

Cell-specific and athero-protective roles for RIPK3 in a murine model of atherosclerosis
по: Sarah Colijn, и др.
Опубликовано: (2020-01-01)

Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer
по: Pal Maurovich-Horvat, и др.
Опубликовано: (2023-07-01)

Statins and immune checkpoint inhibitors: a strategy to improve the efficacy of immunotherapy for cancer?
по: Esther Lutgens, и др.
Опубликовано: (2022-09-01)

miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors
по: Florian Huemer, и др.
Опубликовано: (2021-01-01)

Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease
по: Esther Lutgens, и др.
Опубликовано: (2020-05-01)

Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma
по: Vafa Meftahpour, и др.
Опубликовано: (2022-01-01)

Therapeutic Ultrasound-Enhanced Immune Checkpoint Inhibitor Therapy
по: Jinyun Yuan, и др.
Опубликовано: (2021-03-01)

Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
по: Naoki Hama, и др.
Опубликовано: (2022-01-01)

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
по: Akintunde Akinleye, и др.
Опубликовано: (2019-09-01)

Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
по: Naoki Hama, и др.
Опубликовано: (2020-10-01)

From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer
по: Yibin Zhou, и др.
Опубликовано: (2024-02-01)

Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies
по: Stephanie C. Pitts, и др.
Опубликовано: (2024-05-01)

Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine
по: Pournima Kadam, и др.
Опубликовано: (2020-11-01)

Immune checkpoint molecules in prevention and development of asthma
по: Zahra Kanannejad, и др.
Опубликовано: (2023-02-01)

Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem
по: Esther Lutgens, и др.
Опубликовано: (2021-06-01)

Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
по: Jared M. Newton, и др.
Опубликовано: (2019-08-01)

The Alcohol–High-Density Lipoprotein Athero-Protective Axis
по: Corina Rosales, и др.
Опубликовано: (2020-07-01)

Immune checkpoint analysis in ear cancer
по: M. Klein, и др.
Опубликовано: (2023-11-01)

Biomarkers for immune checkpoint blockers
по: Kirsty Wienand, и др.
Опубликовано: (2018-06-01)

Immune Checkpoints in Viral Infections
по: Huiming Cai, и др.
Опубликовано: (2020-09-01)

Immune checkpoint blockade in HIV
по: Celine Gubser, и др.
Опубликовано: (2022-02-01)

Immune Checkpoint Inhibitors and the Heart
по: Diana Larisa Mocan-Hognogi, и др.
Опубликовано: (2021-09-01)

Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process
по: E. Anglés-Cano
Опубликовано: (1997-11-01)

Metabolic modulation of melanoma enhances the therapeutic potential of immune checkpoint inhibitors
по: Zafer Gurel, и др.
Опубликовано: (2024-10-01)

Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors
по: Magalie Dosset, и др.
Опубликовано: (2020-07-01)

Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
по: Mark P. Chao, и др.
Опубликовано: (2020-01-01)

Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets
по: Xueyin Zhou, и др.
Опубликовано: (2022-05-01)

Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression
по: Margaret A. McBride, и др.
Опубликовано: (2021-02-01)

Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases
по: Yujia Zhai, и др.
Опубликовано: (2021-04-01)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
по: Nicholas Gravbrot, и др.
Опубликовано: (2019-10-01)

Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade
по: Alice Mougel, и др.
Опубликовано: (2019-03-01)

Editorial: Co-inhibitory immune checkpoint proteins as biomarkers and therapeutic targets in cancer
по: Caroline E. Nunes-Xavier
Опубликовано: (2024-09-01)

Low HDL-C level is associated with the development of intracranial artery stenosis: analysis from the Chinese IntraCranial AtheroSclerosis (CICAS) study.
по: Yining Qian, и др.
Опубликовано: (2013-01-01)

Editorial: The therapeutic inhibition of macrophage checkpoints
по: Alexandre P. A. Theocharides, и др.
Опубликовано: (2024-04-01)

CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide.
по: Kuang-Yuh Chyu, и др.
Опубликовано: (2012-01-01)